VRL-Eurofins >> Testing Services >> Donor Eligibility Screening

Donor Eligibility Screening

Sidebar Image

We perform infectious disease testing by serological and nucleic acid methodologies. Analyzed pathogens depend on the tissue or cells tested as prescribed by 21 CFR 1271. A part from HIV and Hepatitis testing that are routinely performed in all donors, additional screening may include West Nile Virus, EBV, Chagas, Strongyloides, Toxoplasmosis, Human T-lymphotropic virus and Cytomegalovirus (CMV). Reproductive donors must always be tested for Chlamydia trachomatis and Neisseria gonorrhea.

HCT/P Testing Requirements

Assay offerings include:

  • HIV 1/2
  • Hepatitis B Surface Antigen
  • Hepatitis C
  • Hepatitis B Core
  • Syphilis
  • CMV
  • Chlamydia/gonorrhea DNA
  • Trypanosoma cruzi
  • HIV-1/HCV/HBV Nucleic Acid Test
  • WNV Nucleic Acid Test
  • Confirmatory Assays

Donor Eligibility Testing Services support:

  • Solid Organ Transplantation
  • Musculoskeletal Tissues
  • Cornea
  • Cord Blood/Bone Marrow/Cellular Therapies
  • Reproductive Health